NuPathe to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
(firmenpresse) - CONSHOHOCKEN, PA -- (Marketwire) -- 11/08/11 -- NuPathe Inc. (NASDAQ: PATH), an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that , chief executive officer, will present a company overview at the Lazard Capital Markets 8th Annual Healthcare Conference on Tuesday, November 15, 2011 at 2:30 p.m. EST. The conference is being held at the Pierre Hotel in New York, NY.
A live audio webcast of the presentation will be available via the "Investor Relations" page of the NuPathe website, . Please log on through NuPathe's website approximately 10 minutes prior to the scheduled start time. A replay of the webcast will also be archived on the Company's website for 90 days following the presentation.
NuPathe Inc. () is an emerging biopharmaceutical company focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. NuPathe's lead product candidate, , is an active, single-use, transdermal sumatriptan patch being developed for the treatment of migraine. In addition to NP101, NuPathe has two additional proprietary product candidates in preclinical development: for the continuous symptomatic treatment of Parkinson's disease, which the company plans to partner, and for the long-term treatment of schizophrenia and bipolar disorder.
John Woolford
Westwicke Partners, LLC
(443) 213-0506
Keith A. Goldan
Vice President & Chief Financial Officer
NuPathe Inc.
(484) 567-0130
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2011 - 08:02 Uhr
Sprache: Deutsch
News-ID 1054582
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CONSHOHOCKEN, PA
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 113 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NuPathe to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
NuPathe Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
